Serological response to vaccination against coronavirus disease-19 in patients with inflammatory bowel disease

Vaccination against coronavirus disease-19 (COVID-19) is effective in preventing the occurrence or reduction in the severity of the infection. Patients with inflammatory bowel disease (IBD) are on immunomodulators, which may alter serological response to vaccination against COVID-19. Accordingly, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathur, Akash, Sahu, Shikha, Rai, Sushmita, Ghoshal, Ujjala, Ghoshal, Uday C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811048/
https://www.ncbi.nlm.nih.gov/pubmed/36598745
http://dx.doi.org/10.1007/s12664-022-01323-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811048/
https://www.ncbi.nlm.nih.gov/pubmed/36598745
http://dx.doi.org/10.1007/s12664-022-01323-7

Ejemplares similares